156 related articles for article (PubMed ID: 15763135)
21. Enhanced dopamine uptake in the striatum following repeated restraint stress.
Copeland BJ; Neff NH; Hadjiconstantinou M
Synapse; 2005 Sep; 57(3):167-74. PubMed ID: 15945060
[TBL] [Abstract][Full Text] [Related]
22. Approaches to identify monoamine transporter interacting proteins.
Torres GE; Caron MG
J Neurosci Methods; 2005 Apr; 143(1):63-8. PubMed ID: 15763137
[No Abstract] [Full Text] [Related]
23. Acute ethanol decreases dopamine transporter velocity in rat striatum: in vivo and in vitro electrochemical measurements.
Robinson DL; Volz TJ; Schenk JO; Wightman RM
Alcohol Clin Exp Res; 2005 May; 29(5):746-55. PubMed ID: 15897718
[TBL] [Abstract][Full Text] [Related]
24. Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens.
Cedeño N; Urbina M; Obregón F; Lima L
J Neuroimmunol; 2005 Feb; 159(1-2):31-40. PubMed ID: 15652400
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters.
Carroll FI; Blough BE; Nie Z; Kuhar MJ; Howell LL; Navarro HA
J Med Chem; 2005 Apr; 48(8):2767-71. PubMed ID: 15828814
[TBL] [Abstract][Full Text] [Related]
26. Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulation.
Ikeda T; Kurosawa M; Uchikawa C; Kitayama S; Nukina N
Biochem Biophys Res Commun; 2005 Feb; 327(1):218-24. PubMed ID: 15629452
[TBL] [Abstract][Full Text] [Related]
27. The dopamine transporter: role in neurotoxicity and human disease.
Bannon MJ
Toxicol Appl Pharmacol; 2005 May; 204(3):355-60. PubMed ID: 15845424
[TBL] [Abstract][Full Text] [Related]
28. The up-regulation of the striatal dopamine transporter's activity by cAMP is PKA-, CaMK II- and phosphatase-dependent.
Page G; Barc-Pain S; Pontcharraud R; Cante A; Piriou A; Barrier L
Neurochem Int; 2004 Oct; 45(5):627-32. PubMed ID: 15234104
[TBL] [Abstract][Full Text] [Related]
29. Fragmentation pathway of dopamine transporter ligands: N-substituted-2beta-carbomethoxy-3beta-phenylnortropane derivatives.
Mavel S; Abarbri M; Frangin Y; Duchène A; Emond P
J Pharm Biomed Anal; 2004 Apr; 35(1):193-8. PubMed ID: 15030894
[TBL] [Abstract][Full Text] [Related]
30. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
Mason JN; Farmer H; Tomlinson ID; Schwartz JW; Savchenko V; DeFelice LJ; Rosenthal SJ; Blakely RD
J Neurosci Methods; 2005 Apr; 143(1):3-25. PubMed ID: 15763132
[TBL] [Abstract][Full Text] [Related]
31. Sp1 and Sp3 activate transcription of the human dopamine transporter gene.
Wang J; Bannon MJ
J Neurochem; 2005 Apr; 93(2):474-82. PubMed ID: 15816870
[TBL] [Abstract][Full Text] [Related]
32. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.
Meiergerd SM; McElvain JS; Schenk JO
Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677
[TBL] [Abstract][Full Text] [Related]
33. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm.
Byas-Smith MG; Li J; Szlam F; Eaton DC; Votaw JR; Denson DD
Synapse; 2004 Aug; 53(2):68-73. PubMed ID: 15170819
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
Carroll FI; Tyagi S; Blough BE; Kuhar MJ; Navarro HA
J Med Chem; 2005 Jun; 48(11):3852-7. PubMed ID: 15916437
[TBL] [Abstract][Full Text] [Related]
35. Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
Kimura M; Masuda T; Yamada K; Kawakatsu N; Kubota N; Mitani M; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
Bioorg Med Chem Lett; 2004 Aug; 14(16):4287-90. PubMed ID: 15261288
[TBL] [Abstract][Full Text] [Related]
36. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations.
Earles C; Wayment H; Green M; Schenk JO
Methods Enzymol; 1998; 296():660-75. PubMed ID: 9779481
[No Abstract] [Full Text] [Related]
37. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ
Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541
[TBL] [Abstract][Full Text] [Related]
38. Studying monoamine transporters: beyond hypermonoaminaemia.
Reith ME
J Neurosci Methods; 2005 Apr; 143(1):1-2. PubMed ID: 15763131
[No Abstract] [Full Text] [Related]
39. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
Zhang S; Zhen J; Reith ME; Dutta AK
J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
[TBL] [Abstract][Full Text] [Related]
40. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry.
Greco PG; Garris PA
Eur J Pharmacol; 2003 Oct; 479(1-3):117-25. PubMed ID: 14612143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]